Merit Medical Systems Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 20.05
Dividend & YieldN/A$ (N/A)
Beta 1.04
Market capitalization 3.99B
Operating cash flow 132.1M
ESG Scores unknown

Company description

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Sector: Healthcare - Industry: Medical Instruments & Supplies

Financial Ratios
Quick Ratio1.1
Working Capital0.2
Return On Equity0.05
Debt To Equity0.23
Fixed Asset Ratio0.23
Fixed Interest Cover19.58

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 15.73M -2.29M 333k 6.05M
Total Cashflows From Investing Activities -378.82M -134.48M -58.65M -37.16M
Net Borrowings 116.5M 44.5M -88.38M -108.5M
Total Cash From Financing Activities 328.28M 33.53M -95.71M -98.44M
Change To Operating Activities 8.2M -4.95M -4.79M 8.85M
Issuance Of Stock 214.99M 6.25M 6.63M 21.31M
Net Income 42.02M 5.45M -9.84M 48.45M
Change In Cash 35.02M -23.04M 12.6M 10.83M
Effect Of Exchange Rate -970k 96k 1.68M -801k
Total Cash From Operating Activities 86.53M 77.81M 165.27M 147.23M
Depreciation 69.55M 104.36M 106.82M 95.78M
Change To Account Receivables -27.52M -17.9M 10.43M -8.62M
Other Cashflows From Financing Activities -597k -17.22M -13.1M -10.66M
Change To Netincome 9.41M 22.78M 33.45M 20.23M
Capital Expenditures -63.32M -78.17M -45.99M -27.94M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 59.53M 65.61M 57.54M 71.25M
Income Before Tax 49.52M 2.19M -13.23M 53.92M
Net Income 42.02M 5.45M -9.84M 48.45M
Selling General Administrative 261.92M 323.77M 296.42M 311.09M
Gross Profit 394.77M 432.37M 401.18M 485.33M
Ebit 73.32M 42.98M 47.22M 103M
Operating Income 73.32M 42.98M 47.22M 103M
Interest Expense -10.36M -12.41M -9.99M -5.26M
Income Tax Expense 7.5M -3.26M -3.39M 5.46M
Total Revenue 882.75M 994.85M 963.88M 1.07B
Cost Of Revenue 487.98M 562.49M 562.7M 589.42M
Total Other Income ExpenseNet -23.8M -40.78M -60.45M -49.08M
Net Income From Continuing Ops 42.02M 5.45M -9.84M 48.45M
Net Income Applicable To Common Shares 42.02M 5.45M -9.84M 48.45M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 687.24M 807.38M 705.82M 608.5M
Total Stockholder Equity 932.77M 949.94M 958.58M 1.04B
Other Current Liabilities 27.45M 31.71M 21.91M 37.47M
Total Assets 1.62B 1.76B 1.66B 1.65B
Common Stock 571.38M 587.02M 606.22M 641.53M
Other Current Assets 5.66M 5.47M 6.34M 5.61M
Retained Earnings 363.43M 368.22M 357.8M 406.26M
Treasury Stock -2.03M -5.29M -5.45M -7.99M
Cash 67.36M 44.32M 56.92M 67.75M
Total Current Liabilities 175.34M 181.66M 185M 236.28M
Other Stockholder Equity -2.03M -5.29M -5.45M -7.99M
Property, Plant, and Equipment 331.45M 459.03M 460.97M 437.57M
Total Current Assets 429.83M 454.54M 429.71M 482.21M
Net Tangible Assets 134.63M 151.44M 227.13M 358.79M
Net Receivables 149.38M 168.53M 157.96M 172.84M
Accounts Payable 54.02M 54.62M 49.84M 55.62M


Insider Transactions

Here are the insider transactions of stock shares related to Merit Medical Systems Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
WRIGHT JOSEPH CConversion of Exercise of derivative security at price 16.05 per share.D2022-11-07Officer15k
WRIGHT JOSEPH CSale at price 63.25 per share.D2022-08-15Officer5k
WRIGHT JOSEPH CConversion of Exercise of derivative security at price 16.05 per share.D2022-08-15Officer5k
LLOYD BRIAN GSale at price 62.00 - 62.03 per share.D2022-08-12Officer26.9k
LLOYD BRIAN GConversion of Exercise of derivative security at price 28.20 per share.D2022-08-12Officer30k
PARRA RAUL JR.Sale at price 62.70 - 62.74 per share.D2022-08-12Chief Financial Officer2.34k
PARRA RAUL JR.Conversion of Exercise of derivative security at price 28.20 per share.D2022-08-12Chief Financial Officer2k
LAMPROPOULOS FRED PConversion of Exercise of derivative security at price 16.05 per share.D/I2022-08-10Chief Executive Officer56k
FROST RONALD ASale at price 62.10 per share.D2022-08-10Chief Operating Officer20k
FROST RONALD AConversion of Exercise of derivative security at price 16.05 per share.D2022-08-10Chief Operating Officer20k
PETERSON NEILSale at price 58.10 per share.D2022-08-01Chief Operating Officer4k
PETERSON NEILConversion of Exercise of derivative security at price 16.05 per share.D2022-08-01Chief Operating Officer4k
MILLNER F ANNSale at price 61.92 per share.D2022-06-03Director6.38k
MILLNER F ANNConversion of Exercise of derivative security at price 18.80 per share.D2022-06-03Director10k
ANDERSON ALDON SCOTTStock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
FLOYD DAVID KStock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
CARPENTER LONNY JStock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
MILLNER F ANNStock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
GUNDERSON THOMAS JAMESStock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
KAISER LAURA S.Stock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
WARD LYNNE N.Stock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
HOGAN JAMES TStock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
MCDONNELL MICHAEL RStock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
EVANS STEPHEN CStock Award(Grant) at price 0.00 per share.D2022-05-24Director3.05k
LLOYD BRIAN GStock Gift at price 0.00 per share.D2022-03-30Officer640
LAMPROPOULOS FRED PStock Award(Grant) at price 0.00 per share.D2022-02-25Chief Executive Officer17.68k
WRIGHT JOSEPH CStock Award(Grant) at price 0.00 per share.D2022-02-25Officer6.63k
FROST RONALD AStock Award(Grant) at price 0.00 per share.D2022-02-25Chief Operating Officer6.63k
LLOYD BRIAN GStock Award(Grant) at price 0.00 per share.D2022-02-25Officer6.63k
PARRA RAUL JR.Stock Award(Grant) at price 0.00 per share.D2022-02-25Chief Financial Officer6.63k
LLOYD BRIAN GStock Gift at price 0.00 per share.D2021-12-28Officer1.85k
WRIGHT JOSEPH CSale at price 72.01 per share.D2021-09-15Officer10k
WRIGHT JOSEPH CConversion of Exercise of derivative security at price 17.27 per share.D2021-09-15Officer10k
LLOYD BRIAN GSale at price 71.76 - 71.88 per share.D2021-09-15Officer19k
LLOYD BRIAN GConversion of Exercise of derivative security at price 28.20 per share.D2021-09-15Officer20k
WARD LYNNE N.Sale at price 71.83 per share.D2021-09-15Unknown9.47k
WARD LYNNE N.Conversion of Exercise of derivative security at price 34.46 per share.D2021-09-15Unknown14.87k
ANDERSON JILLSale at price 71.64 per share.D2021-09-10Director850
PARRA RAUL JR.Sale at price 72.00 - 72.01 per share.D2021-09-09Chief Financial Officer4k
PARRA RAUL JR.Conversion of Exercise of derivative security at price 44.80 per share.D2021-09-09Chief Financial Officer4k
LAMPROPOULOS FRED PConversion of Exercise of derivative security at price 17.27 per share.I2021-09-08Chief Executive Officer5k
ANDERSON ALDON SCOTTStock Award(Grant) at price 0.00 per share.D2021-06-17Director2.91k
FLOYD DAVID KStock Award(Grant) at price 0.00 per share.D2021-06-17Director2.91k
CARPENTER LONNY JStock Award(Grant) at price 0.00 per share.D2021-06-17Director2.91k
MILLNER F ANNStock Award(Grant) at price 0.00 per share.D2021-06-17Director2.91k
GUNDERSON THOMAS JAMESStock Award(Grant) at price 0.00 per share.D2021-06-17Director2.91k
ANDERSON JILLStock Award(Grant) at price 0.00 per share.D2021-06-17Director2.91k
WARD LYNNE N.Stock Award(Grant) at price 0.00 per share.D2021-06-17Director2.91k
HOGAN JAMES TStock Award(Grant) at price 0.00 per share.D2021-06-17Director2.91k
EVANS STEPHEN CStock Award(Grant) at price 0.00 per share.D2021-06-17Director2.91k
FROST RONALD ASale at price 61.82 per share.D2021-06-15Chief Operating Officer11.89k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Merit Medical Systems Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Merit Medical Systems Inc

Here is the result of two systematic investment strategies applied to Merit Medical Systems Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Merit Medical Systems Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Merit Medical Systems Inc:

Merit Medical Systems Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 52.17% on the backtest period.

Performance at glance

Performance

52.17 %

Latent gain

1189.13 $

Invested capital

2279.35 $

Annualized return

12.6 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Merit Medical Systems Inc

This is the result of two momentum investment strategies applied to Merit Medical Systems Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Merit Medical Systems Inc

The following chart shows all the entries opened by the momentum investment system on Merit Medical Systems Inc:

Merit Medical Systems Inc momentum entries
  • The first momentum investment strategy would give 53.32% of return on Merit Medical Systems Inc. That represents 3115.91$ of latent gain with 5844.33$ of employed capital.
  • The second momentum investment strategy would give 50.17% of return on Merit Medical Systems Inc. That represents 1834.76$ of latent gain with 3657.0$ of employed capital.
Performance at glance (1Q Momentum)

Performance

53.32 %

Latent gain

3115.91 $

Invested capital

5844.33 $

Annualized return

73.31 %
Performance at glance (2Q Momentum)

Performance

50.17 %

Latent gain

1834.76 $

Invested capital

3657.0 $

Annualized return

13.71 %

Momentum equity curve on Merit Medical Systems Inc

The following chart shows the equity curve of the two momentum strategies applied to Merit Medical Systems Inc:

Merit Medical Systems Inc momentum equity

Note: the dividends potentially given by Merit Medical Systems Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Merit Medical Systems Inc

The following chart shows the employed capital evolution of the two momentum strategies on Merit Medical Systems Inc since the beginning:

Merit Medical Systems Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Merit Medical Systems Inc

Buy the dip entry openings on Merit Medical Systems Inc

Merit Medical Systems Inc

The performance achieved by the robo-advisor on Merit Medical Systems Inc is 156.89%. That represents 1544.58$ of latent gain with 984.52$ of employed capital. The following chart shows Merit Medical Systems Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Merit Medical Systems Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

156.89 %

Latent gain

1544.58 $

Invested capital

984.52 $

Annualized return

73.31 %

Equity curve of the strategy applied to Merit Medical Systems Inc

The following chart shows the result of the investment strategy applied to Merit Medical Systems Inc:

Merit Medical Systems Inc

Note: the dividends potentially given by Merit Medical Systems Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Merit Medical Systems Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Merit Medical Systems Inc:

Merit Medical Systems Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Merit Medical Systems Inc

In this section, I will compare the three previous investment strategies applied to Merit Medical Systems Inc.

Equity curve comparison on Merit Medical Systems Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Merit Medical Systems Inc investment strategy comparison

Employed capital comparison on Merit Medical Systems Inc

Merit Medical Systems Inc investment comparison

Performance comparison on Merit Medical Systems Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 52.17% 1189.13$ 2279.35$ 12.6%
Momentum 1 quarter 53.32% 3115.91$ 5844.33$ 13.67%
Momentum 2 quarters 50.17% 1834.76$ 3657.0$ 13.71%
Non-directional 156.89% 1544.58$ 984.52$ 73.31%
Annualized return comparison

Automatic investment

12.6 %

Momentum 1Q

13.71 %

Momentum 2Q

13.71 %

Non-directional

73.31 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Merit Medical Systems Inc:

Positive correlations

Most correlated stocks this year

  • Merit Medical Systems Inc

  • Most correlated stocks last 3 months

  • Armata Pharmaceuticals Inc
  • Merit Medical Systems Inc

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between Merit Medical Systems Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Merit Medical Systems Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Merit Medical Systems Inc
    Country United States
    City South Jordan
    Address 1600 West Merit Parkway
    Phone 801 253 1600
    Website www.merit.com
    FullTime employees 6900
    Industry Medical Instruments & Supplies
    Sector Healthcare
    Exchange XNAS
    Ticker MMSI
    Market www.nasdaq.com

    Merit Medical Systems Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown